Latest News and Press Releases
Want to stay updated on the latest news?
-
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
-
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "DIY Home Improvement Market in US 2023-2027" report has been added to ResearchAndMarkets.com's offering.The DIY home improvement market is forecasted...
-
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Sand Paper Market by Type (Fine Particle, Medium Coarseness Particle, Rough Particle), Application (High-End Furniture & Car Polish,...
-
Wilmington, Delaware, United States, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global agricultural biotechnology market is estimated to flourish at a CAGR of 9.5%...
-
Austin, TX, USA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lithium Ion Battery Recycling Market Size, Trends and Insights By Type...
-
New York, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The Global Medical Power Supply Market Size is To Grow from USD 1.42 Billion in 2022 to USD 2.67 Billion by 2032, at a Compound Annual...
-
LexisNexis® Winner Of 2023 LegalTech Breakthrough Award For “Overall Legal Spend Management Solution Of The Year”
-
Holden, Massachusetts, Nov. 14, 2023 (GLOBE NEWSWIRE) -- November 14, 2023– H to O Supply, a prominent online supplier of waterworks and industrial tools, is thrilled to announce the opening of...
-
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
-
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...